-
1 . Academic Journal
A phase III, 52‐week, open‐label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis.
- 저자
- by Fujimoto, Tomoko; Abe, Yoichiro; Igarashi, Masaru; Ishikoh, Akiko; Omi, Tokuya, et al.
- 소스
- Journal of Dermatology; Aug2021, Vol. 48 Issue 8, p1149-1161, 13p
-
7 . Academic Journal
A phase 3, multicenter, randomized, double‐blind, vehicle‐controlled, parallel‐group study of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis.
- 저자
- by Yokozeki, Hiroo; Fujimoto, Tomoko; Abe, Yoichiro; Igarashi, Masaru; Ishikoh, Akiko, et al.
- 소스
- Journal of Dermatology; Mar2021, Vol. 48 Issue 3, p279-288, 10p